Hook Group

All the posts published.

Preliminary Results For The Year Ended 31 December 2020

Mar 31, 2021
-
News, RNS Announcements
NetScientific plc ("NetScientific", “NSCI”, the Group” or the "Company") Preliminary Results for the year ended 31 December 2020 Company poised for further growth, following turnaround, transformation and portfolio expansion DOWNLOAD THE PDF   NetScientific plc (AIM: NSCI), the international life sciences and sustainability, technology investment and commercialisation group, announces its preliminary results for the year [...]

PDS Biotechnology Reports Final Results for the Full Year 2020 & Business Update

Mar 18, 2021
-
News, PDS Biotechnology, RNS Announcements
NetScientific plc ("NetScientific", the “Group” or the "Company") PDS Biotechnology Reports Final Results for the Full Year 2020 & Business Update   London, UK – 18 March 2021 – NetScientific plc (AIM: NSCI), the life sciences and sustainability technology investment and commercialisation Group, announces that its portfolio company, PDS Biotechnology Corporation (“PDS”) (Nasdaq: PDSB) announced its [...]

PDS COVID-19 Vaccine Commercialisation Update

Mar 11, 2021
-
News, PDS Biotechnology, RNS Announcements
NetScientific plc ("NetScientific", the “Group” or the "Company") PDS COVID-19 Vaccine Commercialisation Update c. $60m Funding Commitment by Brazilian government for Clinical Development and Commercialisation of PDS Consortium’s COVID-19 Vaccine London, UK – 11 March 2021 – NetScientific plc (AIM: NSCI), the life sciences and sustainability technology investment and commercialisation Group, announces that PDS Biotech’s [...]

PDS COVID-19 Vaccine Commercialisation Update

Feb 23, 2021
-
News, PDS Biotechnology, RNS Announcements
NetScientific plc ("NetScientific", the “Group” or the "Company")   PDS COVID-19 Vaccine Commercialisation Update   Blanver joins PDS-Farmacore COVID-19 Vaccine Consortium   PDS Biotech and Farmacore Announce Blanver to Join Consortium to Commercialize Novel Versamune®-Based T-Cell Inducing COVID-19 Vaccine   London, UK – 23 February 2021 – NetScientific plc (AIM: NSCI), the life sciences and sustainability [...]

ProAxsis Limited enters licensing agreement with top Swiss University

Feb 22, 2021
-
News, ProAxsis, RNS Announcements
NetScientific plc ("NetScientific" or the "Company") ProAxsis Update London, UK – 22 February 2021 – NetScientific plc (AIM: NSCI), the life sciences and sustainability technology investment and commercialisation Group, announces that its portfolio company ProAxsis Limited ("ProAxsis") has announced that it has entered into a global licensing agreement with the University of Geneva and the University [...]

PDS Phase II Trial Update & Restoration of Trading

Feb 3, 2021
-
News, PDS Biotechnology, RNS Announcements
NetScientific plc ("NetScientific" or the "Company")   PDS Biotech Announces Preliminary Efficacy Achievement in Phase II Combination Trial of PDS0101 Led by the National Cancer Institute   Restoration of Trading   The National Cancer Institute’s (NCI) Phase II clinical study of PDS Biotech’s PDS0101 for HPV-associated cancers has achieved its preliminary objective response. Full enrollment [...]

Suspension of Trading on AIM

Feb 2, 2021
-
News, RNS Announcements
NetScientific plc ("NetScientific" or the "Company") Suspension of Trading on AIM NetScientific plc (AIM: NSCI), the life sciences, technology, investment and commercialisation company, announces that it has a notification obligation pending in respect of one of its portfolio companies. However, the Company is currently not in a position to issue the notification, and as such [...]

Issue of Shares, Director/PDMR Shareholding and Total Voting Rights 

Jan 25, 2021
-
News, RNS Announcements
NetScientific plc ("NetScientific" or the "Company") Issue of Shares, Director/PDMR Shareholding and Total Voting Rights  NetScientific plc (AIM: NSCI), the life sciences, technology, investment and commercialisation company, announces the issue of a total of 101,066 new ordinary shares of £0.05 each in the Company ("New Ordinary Shares") to Chairman John Clarkson, who has chosen to [...]

TR-1: Standard form for notification of major holdings

Jan 4, 2021
-
News, RNS Announcements
TR-1: Standard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii: NetScientific plc 1b. Please indicate if the [...]

PDS Biotech Announces Mount Sinai Publication of Studies Showing Superior Induction of Antibodies by Versamune®-based COVID-19 Vaccine

Dec 21, 2020
-
News, PDS Biotechnology, RNS Announcements
NetScientific plc ("NetScientific" or the "Company") PDS Biotech Announces Mount Sinai Publication of Studies Showing Superior Induction of Antibodies by Versamune®-based COVID-19 Vaccine Versamune® T-cell activating platform demonstrates breadth of anti-SARS-CoV-2 immune responses in a COVID-19 vaccine   London, UK – 21 December 2020 – NetScientific plc (AIM: NSCI), the life sciences, technology, investment and commercialisation company, [...]
Hook Group Archives - NetScientific